ES2108641A1 - Sulfonimidas quinolonicas con accion antagonista de los leucotrienos. - Google Patents

Sulfonimidas quinolonicas con accion antagonista de los leucotrienos.

Info

Publication number
ES2108641A1
ES2108641A1 ES09501537A ES9501537A ES2108641A1 ES 2108641 A1 ES2108641 A1 ES 2108641A1 ES 09501537 A ES09501537 A ES 09501537A ES 9501537 A ES9501537 A ES 9501537A ES 2108641 A1 ES2108641 A1 ES 2108641A1
Authority
ES
Spain
Prior art keywords
hydrogen
och3
alkyl
sulfonimides
quinolone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09501537A
Other languages
English (en)
Other versions
ES2108641B1 (es
Inventor
Domingo Mercedes Alvarez
Casellas David Mauleon
Perez Luisa Garcia
Torro M Desamparados Fos
Farres Rosa Griera
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorios Menarini SA
Original Assignee
Laboratorios Menarini SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Menarini SA filed Critical Laboratorios Menarini SA
Priority to ES9501537A priority Critical patent/ES2108641B1/es
Priority to PCT/EP1996/003168 priority patent/WO1997005114A1/en
Priority to AU66576/96A priority patent/AU6657696A/en
Publication of ES2108641A1 publication Critical patent/ES2108641A1/es
Application granted granted Critical
Publication of ES2108641B1 publication Critical patent/ES2108641B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SULFONIMIDAS QUINOLONICAS CON ACCION ANTAGONISTA DE LOS LEUCOTRIENOS. LA PRESENTE INVENCION SE REFIERE A NUEVAS SULFONIMIDAS QUINOLONICAS DE FORMULA I, FORMULA DONDE EL SUSTITUYENTE QUE CONTIENE A A ESTA UNIDO A LA POSICION 5, 6 O 7; EL SUSTITUYENTE QUE CONTIENE A CONHSO2 ESTA UNIDO A LA POSICION 1 O 2 DEL NUCLEO DE 4-QUINOLONA; R1 ESTA UNIDO A LA POSICION 1 O 2 DEL NUCLEO DE 4-QUINOLONA Y ES HIDROGENO, ALQUILO, -OH, -OCH3, CH2X, X ES -OH, -OCH3 O -COOR8, R8 ES HIDROGENO O ALQUILO; R2 ES HIDROGENO, FLUOR, CLORO, ALQUILO O -OCH3; R3 ES HIDROGENO, FLUOR, CLORO, ALQUILO O -OCH3; R4 ES HIDROGENO, FLUOR, CLORO, O -OCH3; R5 ES HIDROGENO O METILO; R6 ES ALQUILO, CICLOALQUILO O FENILALQUILO; R7 ES HIDROGENO, ALQUILO, -OCH3 O -CH2X; A ES OXIGENO, METILENO O -NR9-; R9 ES HIDROGENO O METILO. DICHOS COMPUESTOS SON ANTAGONISTAS DE LOS LEUCOTRIENOS, PUDIENDO SER UTILIZADOS COMO ANTIINFLAMATORIOS, ANTIALERGICOS O EN EL TRATAMIENTO DE ENFERMEDADES CARDIOVASCULARES.
ES9501537A 1995-07-31 1995-07-31 Sulfonimidas quinolonicas con accion antagonista de los leucotrienos. Expired - Fee Related ES2108641B1 (es)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ES9501537A ES2108641B1 (es) 1995-07-31 1995-07-31 Sulfonimidas quinolonicas con accion antagonista de los leucotrienos.
PCT/EP1996/003168 WO1997005114A1 (en) 1995-07-31 1996-07-18 Quinolone sulfonimides having leukotriene-antagonistic action
AU66576/96A AU6657696A (en) 1995-07-31 1996-07-18 Quinolone sulfonimides having leukotriene-antagonistic action

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9501537A ES2108641B1 (es) 1995-07-31 1995-07-31 Sulfonimidas quinolonicas con accion antagonista de los leucotrienos.

Publications (2)

Publication Number Publication Date
ES2108641A1 true ES2108641A1 (es) 1997-12-16
ES2108641B1 ES2108641B1 (es) 1998-08-16

Family

ID=8291217

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9501537A Expired - Fee Related ES2108641B1 (es) 1995-07-31 1995-07-31 Sulfonimidas quinolonicas con accion antagonista de los leucotrienos.

Country Status (3)

Country Link
AU (1) AU6657696A (es)
ES (1) ES2108641B1 (es)
WO (1) WO1997005114A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9919411D0 (en) * 1999-08-18 1999-10-20 Zeneca Ltd Chemical compounds
GB0716532D0 (en) * 2007-08-24 2007-10-03 Angeletti P Ist Richerche Bio Therapeutic compounds

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0199543A2 (en) * 1985-04-17 1986-10-29 Ici Americas Inc. Heterocyclic amide derivatives

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0199543A2 (en) * 1985-04-17 1986-10-29 Ici Americas Inc. Heterocyclic amide derivatives

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MATASSA V.G. y col. Synthesis and in Vitro LTD, Antagonist Activity of Bicyclic and Monocyclic Cyclopentylurethane and Cyclopentylacetamide N-Arylsulfonyl Amides. J. Med. Chem. 1990, Vol. 33, N‘ 9, pßginas 2621-2629 *

Also Published As

Publication number Publication date
AU6657696A (en) 1997-02-26
WO1997005114A1 (en) 1997-02-13
ES2108641B1 (es) 1998-08-16

Similar Documents

Publication Publication Date Title
YU8703A (sh) Derivati 4-fenil-piridina kao antagonisti receptora neurokinina-1
TW369526B (en) Diazabicyclic neurokinin antagonists
PE20020272A1 (es) N-oxidos de derivados de 4-fenil-piridina como prodrogas de los antagonistas del receptor de neuroquinina 1 (nk-1)
KR930023359A (ko) 8-클로로-11-[1-[(5-메틸-3-피리딜)메틸]-4-피페리딜리덴]-6,11-디히드로-5H-벤조[5,6] 시클로헵타[1,2-b] 피리딘
PT75471B (fr) Procede de preparation d'ethers tricycliques
MX9205242A (es) Compuestos heterociclicos que contienen nitrogeno triciclico fusionado.
DK160877C (da) Fremgangsmaade til fremstilling af 2-penemforbindelser
MY129224A (en) 4-phenyl-pyridine derivatives
WO1998009953A3 (de) Azinyloxy- und phenoxy-diaryl-carbonsäure derivate, deren herstellung und deren verwendung als gemischte eta/etb endothelin-rezeptorantagonist
DK0656353T3 (da) Aminoquinolinderivater med en virkning mod malariafremkaldere
ATE374773T1 (de) Polycyclische verbindungen als potenten alpha2- adrenoceptor antagonisten
KR880012227A (ko) 도파민 수용체 길항제의 신규사용법
DE69022744D1 (de) Piperidin und pyrrolidin derivate.
DE69725457D1 (de) Piperazinderivate als neurokinin-antagonisten
ES2108641A1 (es) Sulfonimidas quinolonicas con accion antagonista de los leucotrienos.
PE20010649A1 (es) Derivados de antranilamida de piperidinas 1,4-di-sustituidas como antagonistas muscarinicos
TR200100660T2 (tr) Piperidin türevleri.
HUP9902040A2 (hu) Új eljárás 4-fenil-1,2,3,6-tetrahidro-piridin-származékok előállítására és az alkalmazott köztitermékek
DK1347965T3 (da) Hidtil ukendte desloratidinsalte, fremgangsmåde til syntese deraf samt farmaceutiske præparater deraf
ES2111086T3 (es) Compuestos triciclicos anfoteros como agentes antihistaminicos y antialergicos.
EA200400656A1 (ru) Новые манделатные соли замещенных тетрациклических производных тетрагидрофурана
IT1303123B1 (it) Derivati basici di benz(e)isoindol-1-oni e pirrolo(3,4-c)chinolin-1-oni ad attivita' 5ht3 antagonista, loro preparazione ed
YU140991A (sh) 3-(1,2-benzizoksazol-3-il)-4-piridinamini i derivati
ES2042997T3 (es) Procedimiento de preparacion de agentes antialergicos y antiinflamatorios a base de dihidropiridinas.
DE69110219D1 (de) 3-(1H-Indazol-3-yl)-4-pyridiname, Verfahren und Zwischenprodukte zu ihrer Herstellung und ihre Verwendung als Arzneimittel.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20060801